Agilent Technologies vs Danaher
A and DHR side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How A and DHR compare
Danaher is the larger company, worth 3.4 times as much as Agilent Technologies ($167B against $49.3B).
On earnings, Agilent Technologies is cheaper: it trades at 34.5× trailing earnings, against 42.1× for Danaher.
Agilent Technologies grew revenue faster over the last twelve months (8.6% versus 4.6% for Danaher).
Agilent Technologies keeps more of each dollar of sales as profit, with a net margin of 19.5% compared with 15.9% at Danaher.
Both pay dividends: Agilent Technologies yields 0.58% and Danaher 0.64%.
Agilent Technologies scores higher on the StockData Score (21 against 12 for Danaher), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | A | DHR |
|---|---|---|
| Size and price | ||
| Market cap | $49.3B | $167B |
| Share price | $174.87 | $236.98 |
| Change, 1 year | 22.1% | 9.3% |
| Change, 5 years | 11.8% | −18.9% |
| Beta (5Y) | 1.04 | 0.94 |
| Employees | 18K | 60K |
| StockData Score | ||
| Total score | 21 (better) | 12 |
| Valuation score | 1 | 1 |
| Growth score | 4 (better) | 1 |
| Performance score | 6 (better) | 2 |
| Health score | 6 (better) | 5 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 34.5× (better) | 42.1× |
| P/S | 6.7× | 6.6× (better) |
| P/B | 6.7× | 3.2× (better) |
| EV/EBITDA | 25.1× (better) | 36.8× |
| P/FCF | 38.9× | 30.5× (better) |
| PEG | 11.43 | – |
| FCF yield | 2.6% | 3.3% (better) |
| Fair value | $149.03 | $186.55 |
| Margin of safety | −17.3% (better) | −27.0% |
| Growth | ||
| Revenue growth (TTM) | 8.6% (better) | 4.6% |
| Revenue growth, 5Y average | 5.4% (better) | 2.0% |
| Net income growth (TTM) | 18.0% (better) | 17.3% |
| EPS growth (TTM) | 18.7% | 19.8% (better) |
| EPS growth, 5Y average | 14.7% (better) | 0.65% |
| Profitability | ||
| Gross margin | 53.8% | 58.5% (better) |
| Operating margin | 22.2% (better) | 20.4% |
| Net margin | 19.5% (better) | 15.9% |
| FCF margin | 17.2% | 21.8% (better) |
| Return on equity | 21.0% (better) | 7.6% |
| Return on invested capital | 26.4% (better) | 6.1% |
| Financial health | ||
| Debt / equity | 0.04 (better) | 0.51 |
| Net debt / EBITDA | −0.76 | 4.33 (better) |
| Interest coverage | 15.5× | 17.6× (better) |
| Current ratio | 2.05 (better) | 1.65 |
| Altman Z-score | 5.79 (better) | 3.77 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.58% | 0.64% (better) |
| Payout ratio | 19.9% | 24.1% |
| Years of dividend growth | 10 | – |
| Dividend growth, 5Y average | 6.6% | – |
| Buyback yield | 0.77% | 1.7% (better) |
| Shareholder yield | 1.4% | 2.4% (better) |
| Ownership | ||
| Held by institutions | 92.8% | 82.2% |
| Held by insiders | 0.29% | 8.9% |
| Insider net buying, 12 months | −$3.2M (better) | −$128M |
| Superinvestors holding | 3 | 10 (better) |
| Short interest, % of float | 1.9% | 1.4% |
Go deeper
- A stock overview
- A income statement
- A valuation and score
- DHR stock overview
- DHR income statement
- DHR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.